Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFAT-regulated gene expression vs trough-level monitoring of ciclosporin in renal transplant recipients
2011-003547-21Phase 4Completed
- Sponsor
- Nierenzentrum Heidelberg
- Start
- Dec 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in kidney transplant, Kidney allograft status (RTx) and kidney allograft rejection (2 arms), sponsored by Nierenzentrum Heidelberg. Primary endpoint: Change in pulse wave velocity. Started Dec 2012; status: completed.
02
Drugs
cyclosporine
03
Conditions
kidney transplantKidney allograft status (RTx)kidney allograft rejection
Beyond the preview
Go deeper on 2011-003547-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003547-21.